Cutaneous Melanoma
📧 Sign up to get email alerts when something new happens for Cutaneous Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin Melanoma [Phase 3]
Clinical trial update on a Phase 3 neoadjuvant study of BCD-217 (Nurulimab + Prolgolimab) in patients with resectable Stage III skin melanom…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Krystal Biotech's KB707 is being studied in a Phase 1/2 trial for locally advanced or metastatic solid tumors, including cutaneous melanoma,…
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: TH1902 in Patients With Advanced Solid Tumors [Phase 1]
This is a Phase 1 clinical trial update for TH1902 in patients with advanced solid tumors. The study is currently active/not recruiting and …
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma [Phase 1]
Phase 1 clinical trial evaluating VX15/2503 with or without ipilimumab and/or nivolumab in patients with resectable stage IIIB–D cutaneous m…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies [Phase 1, Phase 2]
This document reports a Phase 1/Phase 2 clinical trial evaluating GV20-0251 as monotherapy and in combination with pembrolizumab in several …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.
This clinical trial aims to measure the metabolome of melanoma patients using NMR spectroscopy and gas chromatography to analyze differences…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents [Phase 1, Phase 2]
Clinical trial update for OR502, a monoclonal antibody targeting LILRB2, studied alone and with anticancer agents in Phase 1/2; recruitment …
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma [NA]
An ongoing clinical trial is comparing 1 cm versus 2 cm wide surgical excision margins for AJCC Stage II primary cutaneous melanoma and is c…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Versatile Ampification Single-Molecule Detection in Liquid Biopsy
A clinical trial update describes a study of versatile amplification single-molecule detection in liquid biopsy for melanoma. The trial is c…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: IFx-Hu2.0 Expanded Access Program
TuHURA Biosciences reports that the IFx-Hu2.0 Expanded Access Program is available for patients with cutaneous melanoma (Stage III/IV), Merk…
-
CLINICAL_TRIALS research · 2018-07-19Clinical Trial Update: Quality of Life in Patients With Multimetastatic Melanoma Currently in Remission (QUALM)
This document describes a completed clinical trial update focusing on quality-of-life outcomes in patients with cutaneous melanoma that has …
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Natural History Study of Moles and Suspicious Melanoma
The National Cancer Institute-sponsored natural history study on melanocytic nevi and suspicious melanoma has completed, examining how moles…
-
CLINICAL_TRIALS research · 2015-09-02Clinical Trial Update: Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients [Phase 2, Phase 3]
A Phase II/III clinical trial comparing CSF470 plus BCG plus GM-CSF versus interferon alpha-2b in patients with stage IIB/IIC and III cutane…